Earlier this year, our Chief Executive Officer Andrew Witty announced that Glaxo Smith Kline  will sell falciparum circumsporozoite protein  T-cell epitopes hepatitis B surface antigen.
Ku ntandikwa y'omwaka guno, Andrew Witty akulira ekitongole kyaffe yakirangirira nti Glaxo Smith Kline ejja kutunda eddagala lya falciparum circumsporozoite protein  T-cell epitopes hepatitis B surface antigen.